EVALUATION OF THE ASSOCIATION OF ALLELES OF INTOLERANCE RISK TO METOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS UNDER TREATMENT WITH BIOLOGIC THERAPIES

dc.conference.dateJUN 03, 2020
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorEscudero Contreras, A.
dc.contributor.authorOrtega Castro, R.
dc.contributor.authorCalvo Gutierrez, J.
dc.contributor.authorMena-Vazquez, N.
dc.contributor.authorCaliz Caliz, R.
dc.contributor.authorCollantes Estevez, E.
dc.contributor.authorFernandez-Nebro, A.
dc.contributor.authorAbalos-Aguilera, M. D. C.
dc.contributor.authorLopez-Pedrera, C.
dc.contributor.authorRuiz Jimenez, M. T.
dc.contributor.authorPilar, F. U.
dc.contributor.authoraffiliation[Escudero Contreras, A.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Ortega Castro, R.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Calvo Gutierrez, J.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Collantes Estevez, E.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Abalos-Aguilera, M. D. C.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Lopez-Pedrera, C.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Pilar, F. U.] Univ Cordoba, Hosp Univ Reina Sofia, Maimonides Biomed Res Inst Cordoba IMIBIC, Rheumatol, Cordoba, Spain
dc.contributor.authoraffiliation[Mena-Vazquez, N.] Hosp Carlos Haya, Malaga, Spain
dc.contributor.authoraffiliation[Fernandez-Nebro, A.] Hosp Carlos Haya, Malaga, Spain
dc.contributor.authoraffiliation[Caliz Caliz, R.] Complejo Hosp Univ, Granada, Spain
dc.contributor.authoraffiliation[Ruiz Jimenez, M. T.] Roche Farma, Madrid, Spain
dc.date.accessioned2025-01-07T13:37:02Z
dc.date.available2025-01-07T13:37:02Z
dc.date.issued2020-06-01
dc.identifier.doi10.1136/annrheumdis-2020-eular.3258
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/79/Suppl_1/1467.2.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25693
dc.identifier.wosID555905004571
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.number1463-1464
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleEVALUATION OF THE ASSOCIATION OF ALLELES OF INTOLERANCE RISK TO METOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS UNDER TREATMENT WITH BIOLOGIC THERAPIES
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number79
dc.wostypeMeeting Abstract

Files